Jet injection potentiates naked mRNA SARS-CoV-2 vaccine in mice and non-human primates by adding physical stress to the skin
S. Abbasi, M. Matsui-Masai, F. Yasui, A. Hayashi, T. Tockary, S. Akinaga, M. Kohara, K. Kataoka, S. Uchida
Abstract
Naked mRNA-based vaccines may reduce the reactogenicity associated with delivery carriers, but their effectiveness has been suboptimal against infectious diseases. Herein, we aimed to enhance their efficacy by using a pyro-drive liquid jet injector that precisely controls pressure to widely disperse mRNA solution in the skin. The jet injection boosted naked mRNA delivery efficiency in the mouse skin. Mechanistic analyses indicate that dendritic cells, upon uptake of antigen mRNA in the skin, migrate to the draining lymph nodes for antigen presentation. Additionally, the jet injector activated innate immune responses in the skin, presumably by inducing physical stress, thus serving as a physical adjuvant. From a safety perspective, our approach, utilizing naked mRNA, restricted mRNA distribution solely to the injection site, preventing systemic pro-inflammatory reactions following vaccination. Ultimately, the jet injection of naked mRNA encoding SARS-CoV-2 spike protein elicited robust humoral and cellular immunity, providing protection against SARS-CoV-2 infection in mice. Furthermore, our approach induced plasma activity of neutralizing SARS-CoV-2 in non-human primates, comparable to that observed in mice, with no detectable systemic reactogenicity.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Combinational adjuvants delivered by ink-jet potentiate naked mRNA vaccines for robust protection against infectious diseases
Nan Qiao, Junichi Ishikawa, … Satoshi Uchida·bioRxiv·Dec 27, 2025
- mRNA-based vaccine candidate COReNAPCIN(R) induces robust humoral and cellular immunity in mice and non-human primates
R. Alimohammadi, M. Porgoo, … M. Azizi·bioRxiv·Mar 5, 2022
- mRNA vaccine CVnCoV protects non-human primates from SARS-CoV-2 challenge infection
S. Rauch, K. E. Gooch, … M. W. Carroll·bioRxiv·Dec 23, 2020
- Humoral immunogenicity of a Coronavirus Disease 2019 (COVID-19) DNA Vaccine in Rhesus Macaques (Macaca mulatta) Delivered using Needle-free Jet Injection
A. Jay, S. A. Kwilas, … J. W. Hooper·bioRxiv·Sep 12, 2022
- Inhalable polymer nanoparticles for versatile mRNA delivery and mucosal vaccination
A. Suberi, M. K. Grun, … W. M. Saltzman·bioRxiv·Mar 22, 2022
- Optimization of an LNP-mRNA vaccine candidate targeting SARS-CoV-2 receptor-binding domain
K. Kobiyama, M. Imai, … K. J. Ishii·bioRxiv·Mar 4, 2021